Cathie Wood Sells Palantir and AMD, Buys Robinhood and Cerebras Stock: Here's What Else Ark Traded - Pala
Cathie Wood's Ark Invest sold shares of Palantir (PLTR) and AMD (AMD), and bought shares of Robinhood (HOOD) and Cerebras (CBRS). The trades were valued at $6.5M, $9.9M, $3.2M, and $6.5M respectively. Palantir and AMD saw recent partnerships and strong earnings, while Robinhood and Cerebras have seen market volatility.
How this was made
The 30-second read
Why it matters
The disclosed trades provide fresh data on Ark's allocation shifts, offering traders insight into short‑term supply‑demand dynamics for the affected tickers.
Market read
Ark's buying and selling activity can move small‑cap and mid‑cap stocks, creating short‑term trading opportunities.
What to watch
Ark's trades could be part of broader portfolio rebalancing rather than company‑specific sentiment.
Background
Ark Invest regularly reports its fund holdings and trades, influencing market perception of thematic stocks.
Ticker impact
Ark sold 38,395 shares of Palantir, a $6.5M divestiture disclosed today.
Modest downside risk in near term.
Ark's sell signals reduced confidence; size relative to float modest.
Ark sold 19,491 shares of AMD, a $9.9M reduction disclosed today.
Slight short-term dip possible.
Sell follows recent strong earnings; could be profit taking.
Ark bought 27,083 shares of Robinhood, a $3.2M purchase disclosed today.
Potential modest upside.
Buy indicates confidence in Robinhood's growth prospects.
Ark bought 32,561 shares of Cerebras, a $6.5M purchase disclosed today.
Possible short-term rally.
Cerebras' data‑center deal and Ark backing may boost sentiment.
Ark sold 23,808 shares of Twist Bioscience via ARKG, disclosed today.
Limited downside.
Sell size small relative to market.
Ark bought 75,101 shares of Beam Therapeutics via ARKG, disclosed today.
Potential modest upside.
Purchase size modest; limited market effect.
Ark bought 85,317 shares of CRISPR Therapeutics via ARKG, disclosed today.
Slight upward pressure.
Stake increase modest; may not move price significantly.
Ark bought 575,700 shares of Archer Aviation via ARKK, disclosed today.
Potential short-term rally.
Large share count but still small relative to float.
Market effects
Highlights continued interest in AI‑related and biotech stocks by thematic funds.
U.S. equity market sees modest rebalancing from Ark's trades.
Limited; primarily affects U.S. listed companies.
Counterpoint
Ark's sell of PLTR and AMD may be premature given their strong AI positioning.
Key entities
- Investment FundArk Invest
Thematic fund manager led by Cathie Wood.
